Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $221.02 | 5 | 90.3% |
| Education | $23.76 | 3 | 9.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $128.63 | 2 | $0 (2017) |
| Integra LifeSciences Corporation | $62.04 | 3 | $0 (2024) |
| CONMED Corporation | $40.63 | 1 | $0 (2017) |
| BTG INTERNATIONAL, INC. | $13.48 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23.90 | 1 | Integra LifeSciences Corporation ($23.90) |
| 2023 | $38.14 | 2 | Integra LifeSciences Corporation ($38.14) |
| 2020 | $13.48 | 2 | BTG INTERNATIONAL, INC. ($13.48) |
| 2017 | $169.26 | 3 | Amarin Pharma Inc. ($128.63) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Recon-Skin and Wound | ||||||
| 08/11/2023 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Recon-Skin and Wound | ||||||
| 07/28/2023 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Recon-Skin and Wound | ||||||
| 02/10/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Education | Cash or cash equivalent | $6.94 | General |
| Category: ANTI-VENOM | ||||||
| 02/10/2020 | BTG INTERNATIONAL, INC. | CROFAB (Drug) | Education | Cash or cash equivalent | $6.54 | General |
| Category: ANTI-VENOM | ||||||
| 12/16/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $118.35 | General |
| Category: Hypertriglyceridemia | ||||||
| 12/16/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 09/18/2017 | CONMED Corporation | AirSeal (Device) | Food and Beverage | In-kind items and services | $40.63 | General |
| Category: General Surgery | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 713 | 740 | $309,684 | $77,776 |
| 2022 | 6 | 890 | 914 | $246,635 | $61,392 |
| 2021 | 6 | 934 | 952 | $264,595 | $70,606 |
| 2020 | 6 | 1,268 | 1,308 | $359,601 | $94,290 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 253 | 262 | $142,286 | $34,588 | 24.3% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 323 | 337 | $119,727 | $30,763 | 25.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 45 | 47 | $30,691 | $7,587 | 24.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 77 | 79 | $14,931 | $4,382 | 29.3% |
| 99282 | Emergency department visit with straightforward medical decision making | Facility | 2023 | 15 | 15 | $2,049 | $455.28 | 22.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 168 | 173 | $89,441 | $22,740 | 25.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 231 | 239 | $82,694 | $20,540 | 24.8% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 171 | 174 | $32,886 | $8,421 | 25.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 44 | 45 | $29,385 | $7,165 | 24.4% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 242 | 249 | $8,217 | $1,507 | 18.3% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 34 | 34 | $4,012 | $1,020 | 25.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 213 | 217 | $112,189 | $30,481 | 27.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 231 | 233 | $80,618 | $21,340 | 26.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 180 | 187 | $35,343 | $9,759 | 27.6% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 39 | 39 | $25,467 | $6,783 | 26.6% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 249 | 254 | $8,382 | $1,602 | 19.1% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 22 | 22 | $2,596 | $642.01 | 24.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 298 | 309 | $159,753 | $42,910 | 26.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 281 | 288 | $99,648 | $25,933 | 26.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 236 | 247 | $46,683 | $12,308 | 26.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 55 | 56 | $36,568 | $9,487 | 25.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 357 | 367 | $12,111 | $2,426 | 20.0% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2020 | 41 | 41 | $4,838 | $1,226 | 25.3% |
About Dr. Michael Smith, M.D
Dr. Michael Smith, M.D is a Emergency Medicine healthcare provider based in Tulsa, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962432369.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Smith, M.D has received a total of $244.78 in payments from pharmaceutical and medical device companies, with $23.90 received in 2024. These payments were reported across 8 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($221.02).
As a Medicare-enrolled provider, Smith has provided services to 3,805 Medicare beneficiaries, totaling 3,914 services with total Medicare billing of $304,064. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Tulsa, OK
- Active Since 07/03/2006
- Last Updated 12/07/2017
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1962432369
Products in Payments
- Vascepa (Drug) $128.63
- Integra (Device) $62.04
- AirSeal (Device) $40.63
- CROFAB (Drug) $13.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Tulsa
Darnell Blackmon, Md, MD
Emergency Medicine — Payments: $87,410
Dr. Jeffrey Goodloe, M.d, M.D
Emergency Medicine — Payments: $11,859
Jeffrey Johnson, Md, MD
Emergency Medicine — Payments: $5,156
Trung Pham, D.o, D.O
Emergency Medicine — Payments: $3,718
William Gray, Md, MD
Emergency Medicine — Payments: $1,769
Dr. Patricia Ellison-Brown, Do, DO
Emergency Medicine — Payments: $1,507